A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HIV / human immunodeficiency virus

[Related PubMed/MEDLINE]
Total Number of Papers: 39160
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HIV  (>> Co-occurring Abbreviation)
Long Form:   human immunodeficiency virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 "Strap up:" Sexual socialization and safer sex practices among African American youth in foster care. STIs
2019 "This conflict has turned me into a Doctor, Nurse and Nutritionist at the same time": how peer support among HIV-positive IDPs created opportunities for care in conflict-stricken Kabare, Congo DR. IDPs, SSA
2019 'I don't want to be that guy walking in the feminine product aisle': a Photovoice exploration of college men's perceptions of safer sex responsibility. AIDS, STIs
2019 A case of late presentation of darunavir-related cholestatic hepatitis. ---
2019 A comparative study of the various patterns of oro-cutaneous fungi and their sensitivity to anti fungals between HIV patients and normal healthy individuals. AIDS
2019 A Comparison of the Clinical Characteristics and Outcomes of Cryptococcal Meningitis in HIV-negative Individuals With and Without Immunosuppression. CM
2019 A decade of aid coordination in post-conflict Burundi's health sector. ---
2019 A field evaluation of a rapid dual immunoassay for human immunodeficiency virus and syphilis antibodies, Hanoi, Vietnam. CI, MSM, SD BIOLINE DUO, TP
2019 A Focus Group Study of Provider and Patient Perceptions of Communicating Advanced Care Planning Wishes Using Digital Storytelling. ACP, AIDS
10  2019 A high throughput lentivirus sieving assay identifies neutralization resistant Envelope sequences and predicts in vivo sieving. ---
11  2019 A Literature Review of Blood-Disseminated P. marneffei Infection and a Case Study of this Infection in an HIV-Negative Child with Comorbid Eosinophilia. ---
12  2019 A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses. bNAbs, GC, MVA, Tfh, VLPs
13  2019 A Peptide-Mediated Electrochemical Steric Hindrance Assay for One-Step Detection of HIV Antibodies. ---
14  2019 A preliminary analysis of the association between perceived stigma and HIV-related pain in South Africans living with HIV. PLWH
15  2019 A Prospective Comparison of Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome Criteria, Universal Vital Assessment, and Modified Early Warning Score to Predict Mortality in Patients with Suspected Infection in Gabon. AUROC, CI, MEWS, qSOFA, SIRS, UVA
16  2019 A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. VL
17  2019 A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction. HBV, HCV, RAA
18  2019 A rare case of disseminated Mycobacterium avium complex with colitis in a renal transplant recipient. MAC, SOT
19  2019 A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017. TAF, TDF
20  2019 A Review on Quinoline Derived Scaffolds as Anti-HIV Agents. AIDS, HAART, IN
21  2019 A smart nanosensor for the detection of human immunodeficiency virus and associated cardiovascular and arthritis diseases using functionalized graphene-based transistors. afG, AFM, anti-CCP, anti-cTn1, CVDs, FETs, LOD, RA, SEM
22  2019 A systematic review and cost-effectiveness analyses of the new World Health Organization guidelines for the treatment of HIV-positive adults in India. AIDS, ART, CI, WHO
23  2019 Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis. ABC, ARV, DTG, ESRD, HD, PK
24  2019 Accuracy and Operational Characteristics of Xpert Human Immunodeficiency Virus Point-of-Care Testing at Birth and Until Week 6 in Human Immunodeficiency Virus-exposed Neonates in Tanzania. DBS, EID, POC, RNA
25  2019 ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. DMPA, USMEC
26  2019 ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. DMPA, USMEC
27  2019 Acute kidney injury in HIV-infected patients: a critical review. AKI
28  2019 Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States. PrEP, PYAR
29  2019 Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana. ARV
30  2019 Age-responsive human immunodeficiency virus target setting: an opportunity to improve health outcomes among males in Sub-Saharan Africa. ---
31  2019 Amine-Aldehyde Chemical Conjugation on a Potassium Hydroxide-Treated Polystyrene ELISA Surface for Nanosensing an HIV-p24 Antigen. ELISA, Glu, PS
32  2019 An End-User Participatory Approach to Collaboratively Refine HIV Care Data, The New York State Experience. HRSA, NYS
33  2019 An Ethical Framework for Research in Maternal-Fetal Intervention in the Presence of Maternal Human Immunodeficiency Virus or Hepatitis B and C Infection. ---
34  2019 An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa. ALP, ART, CAPRISA, MCV
35  2019 An interview project with native American people: a community-based study to identify actionable steps to reduce health disparities. AI/AN, CBPR, HCV, PWID
36  2019 Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA's and FDA's Views on Initial Dual-Therapy. EMA, FDA, FDC, T2DM
37  2019 Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients. Breg
38  2019 Analytical and Clinical Performance Evaluation of the Elecsys HIV combi PT Assay on the cobas e 602 Analyzer for the Diagnosis of Human Immunodeficiency Virus. CI, FDA
39  2019 Anti-HIV-1 integrase potency of methylgallate from Alchornea cordifolia using in vitro and in silico approaches. AIDS, HIV-1 IN, UNAIDS
40  2019 Antibody responses to viral infections: a structural perspective across three different enveloped viruses. ---
41  2019 Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. ---
42  2019 Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment. AIDS, CNS
43  2019 Assessing the role of transmission chains in the spread of HIV-1 among men who have sex with men in Quebec, Canada. PHI
44  2019 Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes. ID-NAT
45  2019 Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon). HBsAg, HBV
46  2019 Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome. ART, C-IRIS, GXM, LAM, Lam-IgM
47  2019 ASSOCIATION OF SEXUALLY TRANSMITTED DISEASES WITH CERVICAL ECTOPY: A SYSTEMATIC REVIEW. HPV
48  2019 Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men. MSM, STIs
49  2019 Bacterial Sexually Transmitted Infection Screening Rates by Symptomatic Status Among Men Who Have Sex With Men in the United States: A Hierarchical Bayesian Analysis. CrI, Crl, IRR, MSM, STIs
50  2019 Bacterial sexually transmitted infections in France: recent trends and patients' characteristics in 2016. LGV, STI
51  2019 Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in Tanzania. ---
52  2019 Barriers to Accessing Sexual Health Services for Transgender and Male Sex Workers: A Systematic Qualitative Meta-summary. TMSW
53  2019 Behavioral and Clinical Characteristics of American Indian/Alaska Native Adults in HIV Care - Medical Monitoring Project, United States, 2011-2015. HHS, MMP
54  2019 Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial. APRI, ART, CI, FIB-4, HR, START
55  2019 Binding thermodynamics of metal ions to HIV-1 ribonuclease H domain. ITC, RNH
56  2019 Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans. ART, FABP, FASLG, FIB-4, MMP, sCD14, sCD163, VACS
57  2019 Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma. BCBL, HHV-8, LANA1, PEL
58  2019 Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor Monotherapy. CBF, PIM
59  2019 Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region. ---
60  2019 Breastfeeding by Women Living With Human Immunodeficiency Virus in a Resource-Rich Setting: A Case Series of Maternal and Infant Management and Outcomes. cART
61  2019 Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma. cART, NHL, PEL
62  2019 Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population. HCV
63  2019 Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide. bNAbs, Env, FP
64  2019 Cardiac Dysfunction Among PeopleLiving With HIV: A Systematic Review and Meta-Analysis. LVSD
65  2019 Caregivers and community perceptions of blood transfusion for children with severe anaemia in Uganda. ---
66  2019 Case Report: Hemophagocytic Lymphohistiocytosis Caused by Disseminated Histoplasmosis in a Venezuelan Patient with HIV and Epstein-Barr Virus Reactivation Who Traveled to Japan. HLH, PCR
67  2019 Casting a wider net: Immunosurveillance by nonclassical MHC molecules. MHC, TB, TCR
68  2019 CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics. ITM, WHO
69  2019 CD8+ Cytotoxic-T-Lymphocyte Breadth Could Facilitate Early Immune Detection of Immunodeficiency Virus-Derived Epitopes with Limited Expression Levels. CTL, MHC-I, SIV
70  2019 CD8+ T cell-based strong selective pressure on multiple simian immunodeficiency virus targets in macaques possessing a protective MHC class I haplotype. MHC-I, SIV
71  2019 Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. aIRRs, CI
72  2019 Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. ART, IPT, TB
73  2019 Challenges in the treatment of psoriasis with biologics: vaccination, history of malignancy, human immunodeficiency virus (HIV) infection, and pediatric psoriasis. ---
74  2019 Changes of body immunity and inflammatory response in HIV/HCV co-infected patients. AST, HCV, hs-CRP, IgG, IL-1, TNF-alpha
75  2019 Changing Spectrum of Opportunistic Illnesses among HIV-Infected Taiwanese Patients in Response to a 10-Year National Anti-TB Programme. AIDS, Mtb, TB
76  2019 Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017. HBV, HCV, IDU, IRDs, SRDs
77  2019 Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility. ---
78  2019 Chemotherapeutic options for the treatment of human trichomoniasis. ---
79  2019 Chlamydia, Gonorrhea, and Human Immunodeficiency Virus Infection Among Transgender Women and Transgender Men Attending Clinics that Provide Sexually Transmitted Disease Services in Six US Cities: Results From the Sexually Transmitted Disease Surveillance Network. STDs
80  2019 Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study. CLD, RR, TB
81  2019 Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms. CNS, HIVE
82  2019 Clinical and microbiological characteristics of paracoccidioidomycosis in patients with AIDS in Buenos Aires, Argentina. Pm
83  2019 Clinical characteristics, drug resistance, and pathogenic spectrum of patients co-infected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, Sichuan, China. AIDS, chi, MAC, NTM
84  2019 Clinical evaluation of anal intraepithelial neoplasia: are we missing the boat? AIN, SCC
85  2019 Coccidioidomycosis in selected immunosuppressed hosts. AIDS, TNF-alpha
86  2019 Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells. ---
87  2019 Combining surveillance systems to investigate local trends in tuberculosis-HIV co-infection. CI, TB
88  2019 Community perceptions of paediatric severe anaemia in Uganda. ---
89  2019 Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection. cART, CSF, FKN, GNR, MBA
90  2019 Comparison of Plasma Zinc Levels Among HIV+ and HIV- Subjects Infected with Condyloma Acuminata HPV, IFN-gamma, IL-2
91  2019 Condylomata Acuminata (Anogenital Warts) Contain Accumulations of HIV-1 Target Cells That May Provide Portals for HIV Transmission. AGWs
92  2019 Control of viral infections by epigenetic-targeted therapy. HCMV
93  2019 Coronary Artery Disease Manifestations in HIV: What, How, and Why. CAD
94  2019 Correlates of Sexually Transmitted Infections Among South African Women Using Individual- and Community-Level Factors: Results from Generalized Additive Mixed Models. OR, STIs
95  2019 Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study. ART, SHCS
96  2019 Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058. IQR, MSM
97  2019 Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation. AIMS, ICER, QALYs, TAU
98  2019 Curving Tuberculosis: Current Trends and Future Needs. MDR, TB, XDR
99  2019 Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2Cnull Human Immunodeficiency Virus-Infected Individuals. ADCC, HCMV, HLA, NK, PLZF
100  2019 Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naive HIV Patients Tested in a Randomized Placebo-Controlled Trial. BMI, MUAC